Page 19 - மைக்கேல் கிங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Discovery may enable the development of new therapies to kill aggressive cancer cells The idea Vanderbilt faculty and researchers are looking for the Achilles heel of the cancer cells that survive initial chemotherapy. Michael King, chair of the Department of Biomedical Engineering, and Joshua D. Greenlee, graduate research fellow in biomedical engineering, are investigating whether a naturally occurring protein made in immune cells, called TRAIL, is effective in killing colon cancer cells. This knowledge may enable the development of new therapies that make aggressive cancer cells easier to kill off before they spread to other parts of the body. The researchers found that TRAIL is more effective in killing these drug resistant colon cancer cells.

Michael kingJ lawrence wilsonJoshuad greenleeEmily hendersonDepartment of biomedical engineeringBiomedical engineeringWilson professorமைக்கேல் கிங்ஜு லாரன்ஸ் வில்சன்எமிலி ஹென்டர்சன்துறை ஆஃப் உயிர் மருத்துவ பொறியியல்உயிர் மருத்துவ பொறியியல்வில்சன் ப்ரொஃபெஸர்